Pharma Opportunity Certificate
Participate in the fight against the Coronavirus
2020 will go down in history as the year of Covid-19. What initially seemed to be a small epidemic limited to China, has spread out to the entire globe, seriously affecting societies and economies while setting off crisis on all imaginable levels. Get involved in the combat against the Coronavirus and invest in companies that are seeking solutions to put an end to this pandemic.
Pharma Opportunity Certificate
_
There has been an unprecedented eruption of global pharmaceutical research and development related to COVID-19. More than 330 clinical studies and 80 vaccine candidates are currently under review. Big pharma and biotech companies are working to find a drug to manage or defeat COVID-19. With the Pharma Opportunity Certificate, you invest in the performance of companies that are actively working on medicines to combat the coronavirus by developing vaccines or treatments.
Benefits:
• Increased growth potential
• Broad diversification
• Professionally and actively managed
• Traded on the SIX Swiss Exchange
• CHF 9.- flat transaction costs
